# Klotho null mutation leads to retinal degeneration characterized by functional impairment, gliosis, and deposition of amyloid-beta and hyperphosphorylated tau proteins

**Authors:** Zhi-Jia Chen, Chun-Yen Wu, Fang-Yan Hsiao, Jing-Chun Ma, Gabriel Lai, Han-Hsin Chang, David Pei-Cheng Lin

PMC · DOI: 10.1371/journal.pone.0323633 · PLOS One · 2025-05-15

## TL;DR

Klotho gene mutation causes retinal degeneration with functional issues, gliosis, and amyloid-beta and tau protein buildup, similar to age-related eye diseases and Alzheimer's.

## Contribution

This study reveals retinal degeneration in Klotho null mice with amyloid-beta and hyperphosphorylated tau deposits, linking Klotho to retinal health.

## Key findings

- Klotho null mutation causes retinal function impairment detectable via electroretinogram.
- Amyloid-beta and hyperphosphorylated tau protein deposits are present in Klotho mutant retinas.
- Gliosis occurs in Klotho mutant retinas at 10 weeks of age without significant cell death or morphological changes.

## Abstract

Klotho mutation has been known to accelerate aging and degenerative pathogenesis, notably in the kidney and the brain. Nevertheless, the aftermath of Klotho function deprivation in the retina has not been detailed. This study aimed to provide an in-depth analysis of retinopathy caused by Klotho mutation.

The homozygous Klotho mutant mice retinas were analyzed at the 6th, 8th and 10th weeks of age, along with their heterozygous, and wild-type littermates between both genders. The electroretinogram results showed retinal function impairment with Klotho null mutation, as compared with their littermates. Nevertheless, there was no difference in the retinal layer thickness, morphology, and cell death up to 10 weeks of age among the three genotypes. No evident damage was detected in the photoreceptors, interneurons, and retinal ganglion cells with Klotho mutation up to 10 weeks of age. Amyloid-beta and hyperphosphorylated tau protein deposits were detected in the Klotho mutant retina, along with glial cell activation at 10 weeks of age.

The results revealed that Klotho null mutation leads to retinal degeneration characterized by functional impairments, gliosis, and amyloid-beta and hyperphosphorylated tau protein deposition in the retina. Klotho protein function is, therefore, mandatory for the maintenance of a healthy retina. The mouse Klotho null mutation may be used as a study model for age-related retinal degeneration and Alzheimer’s disease.

## Linked entities

- **Genes:** CG9701 (uncharacterized protein) [NCBI Gene 39872]
- **Diseases:** Alzheimer’s disease (MONDO:0004975)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Psen1 (presenilin 1) [NCBI Gene 19164] {aka Ad3h, PS-1, PS1, S182}, Syp (synaptophysin) [NCBI Gene 20977] {aka A230093K24Rik, Syn, p38}, Nefl (neurofilament, light polypeptide) [NCBI Gene 18039] {aka CMT2E, NF-L, NF68, Nfl}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Rho (rhodopsin) [NCBI Gene 212541] {aka Noerg1, Opn2, Ops, RP4}, Gfap (glial fibrillary acidic protein) [NCBI Gene 14580], Dntt (deoxynucleotidyltransferase, terminal) [NCBI Gene 21673] {aka Tdt}, Vegfa (vascular endothelial growth factor A) [NCBI Gene 22339] {aka L-VEGF, Vegf, Vpf}, APP (amyloid beta precursor protein) [NCBI Gene 351] {aka AAA, ABETA, ABPP, AD1, APPI, CTFgamma}, Kl (klotho) [NCBI Gene 16591] {aka alpha-kl}, Gmcl1 (germ cell-less, spermatogenesis associated 1) [NCBI Gene 23885] {aka 2810049L19Rik, Btbd13, DIP, Gcl, Gcl-1, glc-1}, Calb1 (calbindin 1) [NCBI Gene 12307] {aka Brain-2, CB, Calb, Calb-1}, KL (klotho) [NCBI Gene 9365] {aka HFTC3, KLA}, Iba1 (induction of brown adipocytes 1) [NCBI Gene 114737], App (amyloid beta precursor protein) [NCBI Gene 11820] {aka Abeta, Abpp, Adap, Ag, Cvap, E030013M08Rik}
- **Diseases:** NFTs (MESH:D055956), subretinal (MESH:D006949), retinal function (MESH:D012173), memory deficiency (MESH:D008569), retina (MESH:D019572), CNV (MESH:D020256), RGC degeneration (MESH:D012162), ectopic calcification (MESH:D002114), mental failure (MESH:D051437), neuronal damages (MESH:D009410), cognitive deficit (MESH:D003072), osteoporosis (MESH:D010024), Gliosis (MESH:D005911), arteriosclerosis (MESH:D001161), dilated pupils (MESH:D011681), ophthalmologic disorders (MESH:C536647), skin atrophy (MESH:D001284), fibrosis (MESH:D005355), inflammation (MESH:D007249), neurodegeneration (MESH:D019636), amyloid (MESH:C000718787), AD (MESH:D000544), impaired functions in visual acuity (MESH:D014786), retinopathy (MESH:D058437), cognitive abnormalities (MESH:D060825), neuronal and synaptic loss (MESH:D012183), retinal damage (MESH:D012164), retinal detachment (MESH:D012163)
- **Chemicals:** water (MESH:D014867), MYDRIACYL (MESH:D014331), 3,3'- diaminobenzidine (MESH:D015100), H&amp;E (MESH:D006371), citrate (MESH:D019343), Abcam ab150108 (-), CO2 (MESH:D002245), Hematoxylin (MESH:D006416), paraffin (MESH:D010232), xylene (MESH:D014992), DAB (MESH:C000469), Rompun (MESH:D014991), dUTP (MESH:C027078), alcohol (MESH:D000438), DAPI (MESH:C007293), ethanol (MESH:D000431), hydrogen peroxide (MESH:D006861), Eosin Y (MESH:D004801), ALCAINE (MESH:C005717)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** P301S, initiation at 94
- **Cell lines:** RPE — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_GQ00), C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12080808/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12080808/full.md

## References

56 references — full list in the complete paper: https://tomesphere.com/paper/PMC12080808/full.md

---
Source: https://tomesphere.com/paper/PMC12080808